5 Cheap Healthcare Stocks to Buy Now

Page 5 of 5

1. Bristol-Myers Squibb Co (NYSE: BMY)

Forward P/E:     8.28

Bristol-Myers makes treatments and drugs for several diseases, including cancer, HIV/AIDS, cardiovascular disease, diabetes and rheumatoid arthritis. The stock is gaining ground after the company’s non-GAAP EPS and revenue in the fourth quarter beat estimates. Product sales in the quarter jumped 39%.

Warren Buffett’s Berkshire Hathaway is one of the 124 hedge funds tracked by Insider Monkey that reported owning stakes in Bristol at the end of the third quarter. The hedge fund owns $7.6 billion worth of BMY shares.

Wedgewood Partners recently said the following about BMY shares in their Q4 2020 Investor Letter:

“Bristol-Myers Squibb recently reported accelerating sales as much of the medical services industry returned to work. The Company continues to expect double-digit earnings growth over the next few years, driven by existing drugs, in addition to a broad pipeline of new drugs and indications. While the market remains fixated on a couple of patent expirations that could occur over the next several years, we think this is well-known at this point, yet the market still undervalues a couple of key acquisitions the Company has made in the past few years, particularly Celgene, which was acquired for a song.”

You can also read 10 Best Water Stocks and ETFs to Buy in 2021 and 15 Biggest Vaccine Companies In The World.

Page 5 of 5